www.fdanews.com/articles/153199-lycera-expands-partnership-with-merck-for-potential-600-million-deal
Lycera Expands Partnership With Merck for Potential $600 Million Deal
February 13, 2013
Lycera doubled its sweet 2011 deal with Merck in a new agreement designed to expand on the companies’ prior relationship, which has centered on retinoic acid-related orphan receptor.
BioWorld
BioWorld